What is the relationship between neurotransmitters and ADHD?
neurotransmitters and ADHD have shown that most children have diagnosed hyperactivity disorder with clinical symptoms of neurotransmitter imbalances and dysfunction. Some common neurotransmitters and ADHD are associated with the fact that anomalies in the mechanisms of production, transport and reuction of neurotransmitters are assumed that they are present and sometimes easy to display in the brain of ADHD patients. Neurotransmitters of dopamine, norepinephrine and serotonin are the most famous and most commonly targeted in ADHD treatment. For example, low dopamine is considered to be the cause of many primary symptoms of disorder and is treated with stimulant drugs that help the body produce, transport and metabolize the neurotransmitter more efficiently. Norepinephrine and serotonin are newer additions in hypothetical etiology of ADHD; Medicines that focus on these neurotransmitters are used in treatakers.
besides thatIt is associated with neurotransmitters and ADHD that some neurotransmitter mutations may be responsible for subgroups observed in the diagnosis of ADHD. Research suggests that patients with a predominantly inattentive form of disorder have anomalies on the transport gene of norepinephrine, while patients who have more hyperrative symptoms have abnormalities in the transport gene. The Vanderbilt University Research Center states that abnormalities that play an important role in neuronal communication may be present in the brain transport system of choline and has an event comparable to dopamine and norepinephrine. This research shows that newer, more targeted ADHD drugs can be on the horizon. Genetic testing can become an invaluable tool in determining which drug access to the first; An advantage that is particularly awarded when younger children are prescribed strong psychoactive drugs.
The relationship between neurotransmitters and ADHD was further investigated by scientists at Duke University. Scientists have concluded that ritalin, a medicine that noAsto as a defense of the first line in the treatment of ADHD, it acts deeply at dopamine receptors deeply in dopamine. Further testing has shown that treatment with some serotogenic substances such as selective serotonin reuptake inhibitors (SSRI) may help reduce hyperactivity in some patients. In addition, low levels of serotonin are associated with aggression and agitation, both symptoms in some cases ADHD. Serotonin is mediated by 15 separate receptors in the brain, but the targeted serotogenic treatment is a challenge.
other neurotransmitters and ADHD show signs that they can correlate. Fenylethlamine (PEA), identified as a neurotransmitter in 2001, increases activity and alertness in the brain. For this reason, some cases of ADHD look on peas. In addition, dopamine and peas are closely linked to the chemical structure and the hypothesis provide greater credibility.